We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current FBLG market cap is 61.69M. The company's latest EPS is USD -0.5499 and P/E is -2.84.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | ||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.05M | -2.48M | -3.45M | -3.22M | -3.35M |
Net Income | -2.19M | -12.29M | -8.46M | 898k | -500k |
Year End 31 December 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 |
Operating Income | -4.47M | -8.89M |
Net Income | -5.12M | -19.06M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | ||||
Total Assets | 13.3M | 11.82M | 11.4M | 8.91M | 10.47M |
Total Liabilities | 2.76M | 10.57M | 15.26M | 11.3M | 7.73M |
Total Equity | 10.54M | 1.25M | -3.86M | -2.39M | 2.74M |
Year End 31 December 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Total Assets | 4.82M | 11.82M |
Total Liabilities | 8.82M | 10.57M |
Total Equity | -4M | 1.25M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | ||||
Operating | -4.8M | -6.4M | -4.28M | -6.22M | -8.83M |
Investing | -493k | -495k | -8k | -74k | -85k |
Financing | 13.79M | 13.79M | 3.28M | 3.11M | 7.58M |
Year End 31 December 2023 | 2022 | 2023 |
---|---|---|
USD (US$) | USD (US$) | |
Operating | -4.07M | -6.4M |
Investing | N/A | -495k |
Financing | 5.93M | 13.79M |
Market Cap | 61.69M |
Price to Earnings Ratio | -2.84 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 5.9 |
Price to Book Ratio | 43.15 |
Dividend Yield | - |
Shares Outstanding | 34.66M |
Average Volume (1 week) | 274.17k |
Average Volume (1 Month) | 165.68k |
52 Week Change | -94.07% |
52 Week High | 55.00 |
52 Week Low | 1.0779 |
Spread (Intraday) | 0.14 (7.87%) |
Company Name | FibroBiologics Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.fibrobiologics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions